Based on experimental and epidemiological evidence it is hypothesized that estrogen increases breast cancer risk by increasing mitotic activity in breast epithelial cells. Aromatase is crucial to the biosynthesis of estrogens and may therefore play a role in breast cancer development. Supporting data for an etiological role of aromatase in breast tumor biology are several-fold. First, the association between weight and postmenopausal breast cancer risk may be mediated by aromatase. Secondly, a pilot study found a higher aromatase expression in normal breast adipose tissue from breast cancer cases as opposed to healthy women. Thirdly, experimental data in animals suggest that aromatase activity predisposes mammary tissue to preneoplastic and neoplastic changes. In a multiethnic cohort study conducted in Los Angeles and on Hawaii we investigated (i) whether the plasma estrone to androstenedione (E1/A) ratio in different ethnic groups was associated with ethnic differences in breast cancer incidence, and (ii) whether genetic variation in the CYP19 gene encoding the P450 aromatase protein was associated with breast cancer risk. The age- and weight-adjusted ethnic specific E1/A ratios x 100 among women without oophorectomy were 7.92 in African-Americans, 8.22 in Japanese, 10.73 in Latinas and 9.29 in non-Latina Whites (P=0.09). The high E1/A ratio in Latina women was not associated with a high breast cancer incidence; in fact Latina women had the lowest breast cancer incidence in the cohort observed so far. We found no consistent association of an intronic (TTTA)n repeat polymorphism with breast cancer risk in different ethnic groups. This polymorphism was not associated with differences in the plasma E1/A ratio in a way that would predict its functional relevance. We describe a newly identified TTC deletion in intron 5 of the CYP19 gene that is associated with the (TTTA)n repeat polymorphism. Neither this polymorphism, nor a polymorphism at codon 264 in exon VII of the CYP19 gene, was associated with breast cancer. We did not identify any genetic variation in exon VIII in 54 African-American subjects. We identified rare genetic variants of unknown functional relevance in the promoter 1.4 of the CYP19 gene in 3 out of 24 Latina women. Further investigation into the role of aromatase in breast cancer etiology is important, given that the potential use of aromatase inhibitors as breast cancer chemopreventives depends on these results.

This article has been cited by other articles:

				J. A. Cauley, A. Z. LaCroix, L. Wu, M. Horwitz, M. E. Danielson, D. C. Bauer, J. S. Lee, R. D. Jackson, J. A. Robbins, C. Wu, et al. Serum 25-Hydroxyvitamin D Concentrations and Risk for Hip Fractures Ann Intern Med, August 19, 2008; 149(4): 242 - 250. [Abstract] [Full Text] [PDF]

				R. T. Falk, E. Gentzschein, F. Z. Stanczyk, L. A. Brinton, M. Garcia-Closas, O. B. Ioffe, and M. E. Sherman Measurement of Sex Steroid Hormones in Breast Adipocytes: Methods and Implications Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1891 - 1895. [Abstract] [Full Text] [PDF]

				J. S. Lee, A. Z. LaCroix, L. Wu, J. A. Cauley, R. D. Jackson, C. Kooperberg, M. S. Leboff, J. Robbins, C. E. Lewis, D. C. Bauer, et al. Associations of Serum Sex Hormone-Binding Globulin and Sex Hormone Concentrations with Hip Fracture Risk in Postmenopausal Women J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1796 - 1803. [Abstract] [Full Text] [PDF]

				L. J. Shaw, C. N. Bairey Merz, R. Azziz, F. Z. Stanczyk, G. Sopko, G. D. Braunstein, S. F. Kelsey, K. E. Kip, R. M. Cooper-DeHoff, B. D. Johnson, et al. Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health--National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1276 - 1284. [Abstract] [Full Text] [PDF]

				Q. Cai, N. Kataoka, C. Li, W. Wen, J. R. Smith, Y.-T. Gao, X. O. Shu, and W. Zheng Haplotype Analyses of CYP19A1 Gene Variants and Breast Cancer Risk: Results from the Shanghai Breast Cancer Study Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 27 - 32. [Abstract] [Full Text] [PDF]

				D. P. Rose, S. M. Haffner, and J. Baillargeon Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women Endocr. Rev., December 1, 2007; 28(7): 763 - 777. [Abstract] [Full Text] [PDF]

				R. H. Fogle, F. Z. Stanczyk, X. Zhang, and R. J. Paulson Ovarian Androgen Production in Postmenopausal Women J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3040 - 3043. [Abstract] [Full Text] [PDF]

				S. H. Olson, E. V. Bandera, and I. Orlow Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review Am. J. Epidemiol., February 1, 2007; 165(3): 235 - 245. [Abstract] [Full Text] [PDF]

				C. X. Ma, A. A. Adjei, O. E. Salavaggione, J. Coronel, L. Pelleymounter, L. Wang, B. W. Eckloff, D. Schaid, E. D. Wieben, A. A. Adjei, et al. Human Aromatase: Gene Resequencing and Functional Genomics Cancer Res., December 1, 2005; 65(23): 11071 - 11082. [Abstract] [Full Text] [PDF]

				E. J. Aiello, S. S. Tworoger, Y. Yasui, F. Z. Stanczyk, J. Potter, C. M. Ulrich, M. Irwin, and A. McTiernan Associations among Circulating Sex Hormones, Insulin-Like Growth Factor, Lipids, and Mammographic Density in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1411 - 1417. [Abstract] [Full Text] [PDF]

				B. K. Dunn, D. L. Wickerham, and L. G. Ford Prevention of Hormone-Related Cancers: Breast Cancer J. Clin. Oncol., January 10, 2005; 23(2): 357 - 367. [Abstract] [Full Text] [PDF]

				J. Chubak, S. S. Tworoger, Y. Yasui, C. M. Ulrich, F. Z. Stanczyk, and A. McTiernan Associations between Reproductive and Menstrual Factors and Postmenopausal Sex Hormone Concentrations Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1296 - 1301. [Abstract] [Full Text] [PDF]

				A. McTiernan, S. S. Tworoger, K. B. Rajan, Y. Yasui, B. Sorenson, C. M. Ulrich, J. Chubak, F. Z. Stanczyk, D. Bowen, M. L. Irwin, et al. Effect of Exercise on Serum Androgens in Postmenopausal Women: A 12-Month Randomized Clinical Trial Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1099 - 1105. [Abstract] [Full Text] [PDF]

				S. S. Tworoger, Y. Yasui, L. Chang, F. Z. Stanczyk, and A. McTiernan Specimen Allocation in Longitudinal Biomarker Studies: Controlling Subject-Specific Effects by Design Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1257 - 1260. [Abstract] [Full Text] [PDF]

				A. M. Dunning, M. Dowsett, C. S. Healey, L. Tee, R. N. Luben, E. Folkerd, K. L. Novik, L. Kelemen, S. Ogata, P. D. P. Pharoah, et al. Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women J Natl Cancer Inst, June 16, 2004; 96(12): 936 - 945. [Abstract] [Full Text] [PDF]

				A. McTiernan, S. S. Tworoger, C. M. Ulrich, Y. Yasui, M. L. Irwin, K. B. Rajan, B. Sorensen, R. E. Rudolph, D. Bowen, F. Z. Stanczyk, et al. Effect of Exercise on Serum Estrogens in Postmenopausal Women: A 12-Month Randomized Clinical Trial Cancer Res., April 15, 2004; 64(8): 2923 - 2928. [Abstract] [Full Text] [PDF]

				S. S. Tworoger, J. Chubak, E. J. Aiello, C. M. Ulrich, C. Atkinson, J. D. Potter, Y. Yasui, P. L. Stapleton, J. W. Lampe, F. M. Farin, et al. Association of CYP17, CYP19, CYP1B1, and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 94 - 101. [Abstract] [Full Text] [PDF]

				C. A. Haiman, D. O. Stram, M. C. Pike, L. N. Kolonel, N. P. Burtt, D. Altshuler, J. Hirschhorn, and B. E. Henderson A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort Hum. Mol. Genet., October 16, 2003; 12(20): 2679 - 2692. [Abstract] [Full Text] [PDF]

				N. Kado, J. Kitawaki, H. Obayashi, H. Ishihara, H. Koshiba, I. Kusuki, K. Tsukamoto, G. Hasegawa, N. Nakamura, T. Yoshikawa, et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women Hum. Reprod., April 1, 2002; 17(4): 897 - 902. [Abstract] [Full Text] [PDF]

				M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]

				S.W. Baxter, D.Y.H. Choong, D.M. Eccles, and I.G. Campbell Polymorphic variation in CYP19 and the risk of breast cancer Carcinogenesis, February 1, 2001; 22(2): 347 - 349. [Abstract] [Full Text] [PDF]

				Y. Yasui, J. D. Potter, J. L. Stanford, M. A. Rossing, M. D. Winget, M. Bronner, and J. Daling Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection Cancer Epidemiol. Biomarkers Prev., January 1, 2001; 10(1): 9 - 16. [Abstract] [Full Text]